Skip to content
Tenfell
Awarded contract
Published 19 Dec 2017

National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders

NHS England · London

Key facts

Awarded
24 Nov 2017
Contract starts
01 Feb 2018
Contract ends
31 Jan 2019
Procedure
Open procedure
Buyer type
Central government

Awarded to 5 suppliers

SupplierValue
Pfizer Ltd—
Bayer plc—
Novo Nordisk—
Octapharma Limited—
Baxalta UK Limited—

Description

NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.